Citigroup’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $792K | Buy |
44,078
+33,672
| +324% | +$471K | ﹤0.01% | 3622 |
|
|
2026
Q1 | $98K | Sell |
10,406
-4,877
| -32% | -$53.5K | ﹤0.01% | 4295 |
|
|
2025
Q4 | $190K | Sell |
15,283
-16,638
| -52% | -$221K | ﹤0.01% | 4028 |
|
|
2025
Q3 | $457K | Sell |
31,921
-35,471
| -53% | -$486K | ﹤0.01% | 3623 |
|
|
2025
Q2 | $827K | Sell |
67,392
-42,587
| -39% | -$618K | ﹤0.01% | 3304 |
|
|
2025
Q1 | $2.42M | Sell |
109,979
-4,756
| -4% | -$112K | ﹤0.01% | 2532 |
|
|
2024
Q4 | $2.6M | Buy |
114,735
+5,760
| +5% | +$126K | ﹤0.01% | 2592 |
|
|
2024
Q3 | $1.98M | Buy |
108,975
+25,207
| +30% | +$584K | ﹤0.01% | 2674 |
|
|
2024
Q2 | $2.44M | Sell |
83,768
-475
| -0.6% | -$14.1K | ﹤0.01% | 2182 |
|
|
2024
Q1 | $2.99M | Sell |
84,243
-133,430
| -61% | -$5.34M | ﹤0.01% | 2096 |
|
|
2023
Q4 | $9.48M | Buy |
217,673
+35,840
| +20% | +$1.41M | 0.01% | 1248 |
|
|
2023
Q3 | $6.94M | Sell |
181,833
-71,499
| -28% | -$3.01M | 0.01% | 1276 |
|
|
2023
Q2 | $10.4M | Sell |
253,332
-46,073
| -15% | -$2.22M | 0.01% | 1127 |
|
|
2023
Q1 | $17.2M | Sell |
299,405
-99,999
| -25% | -$5.63M | 0.01% | 892 |
|
|
2022
Q4 | $22.4M | Sell |
399,404
-2,794
| -0.7% | -$142K | 0.02% | 744 |
|
|
2022
Q3 | $17M | Sell |
402,198
-53,395
| -12% | -$2.74M | 0.01% | 866 |
|
|
2022
Q2 | $24.6M | Sell |
455,593
-33,412
| -7% | -$2.01M | 0.02% | 698 |
|
|
2022
Q1 | $31.4M | Buy |
489,005
+89,836
| +23% | +$5.91M | 0.02% | 700 |
|
|
2021
Q4 | $26.7M | Buy |
399,169
+7,142
| +2% | +$483K | 0.01% | 860 |
|
|
2021
Q3 | $26.8M | Buy |
392,027
+11,110
| +3% | +$785K | 0.02% | 828 |
|
|
2021
Q2 | $26M | Sell |
380,917
-12,404
| -3% | -$877K | 0.02% | 849 |
|
|
2021
Q1 | $27.2M | Sell |
393,321
-30,276
| -7% | -$2.05M | 0.02% | 787 |
|
|
2020
Q4 | $27.5M | Sell |
423,597
-18,449
| -4% | -$993K | 0.02% | 847 |
|
|
2020
Q3 | $20.9M | Sell |
442,046
-80,329
| -15% | -$3.82M | 0.01% | 882 |
|
|
2020
Q2 | $24.5M | Buy |
522,375
+143,001
| +38% | +$7.03M | 0.02% | 715 |
|
|
2020
Q1 | $16.9M | Buy |
379,374
+372,646
| +5,539% | +$19.6M | 0.02% | 829 |
|
|
2019
Q4 | $392K | Sell |
6,728
-681
| -9% | -$40.5K | ﹤0.01% | 4637 |
|
|
2019
Q3 | $445K | Buy |
7,409
+756
| +11% | +$45K | ﹤0.01% | 4452 |
|
|
2019
Q2 | $372K | Buy |
6,653
+1,100
| +20% | +$56.6K | ﹤0.01% | 4715 |
|
|
2019
Q1 | $310K | Buy |
5,553
+2,132
| +62% | +$109K | ﹤0.01% | 4674 |
|
|
2018
Q4 | $155K | Sell |
3,421
-9,149
| -73% | -$502K | ﹤0.01% | 5263 |
|
|
2018
Q3 | $827K | Sell |
12,570
-2,590
| -17% | -$161K | ﹤0.01% | 3708 |
|
|
2018
Q2 | $976K | Buy |
15,160
+4,161
| +38% | +$258K | ﹤0.01% | 3389 |
|
|
2018
Q1 | $608K | Sell |
10,999
-2,664
| -19% | -$140K | ﹤0.01% | 3793 |
|
|
2017
Q4 | $655K | Buy |
13,663
+2,078
| +18% | +$102K | ﹤0.01% | 3805 |
|
|
2017
Q3 | $584K | Buy |
11,585
+4,868
| +72% | +$250K | ﹤0.01% | 3961 |
|
|
2017
Q2 | $366K | Sell |
6,717
-41,297
| -86% | -$1.97M | ﹤0.01% | 4284 |
|
|
2017
Q1 | $2.02M | Sell |
48,014
-54,414
| -53% | -$2.33M | ﹤0.01% | 2477 |
|
|
2016
Q4 | $4.39M | Buy |
102,428
+61,334
| +149% | +$2.49M | ﹤0.01% | 1979 |
|
|
2016
Q3 | $1.7M | Buy |
41,094
+34,784
| +551% | +$1.46M | ﹤0.01% | 2667 |
|
|
2016
Q2 | $252K | Sell |
6,310
-38,694
| -86% | -$1.39M | ﹤0.01% | 4284 |
|
|
2016
Q1 | $1.52M | Buy |
45,004
+40,260
| +849% | +$1.25M | ﹤0.01% | 2842 |
|
|
2015
Q4 | $161K | Buy |
4,744
+1,940
| +69% | +$60.6K | ﹤0.01% | 4935 |
|
|
2015
Q3 | $83K | Sell |
2,804
-949
| -25% | -$29.7K | ﹤0.01% | 5091 |
|
|
2015
Q2 | $103K | Sell |
3,753
-1,485
| -28% | -$39.6K | ﹤0.01% | 4966 |
|
|
2015
Q1 | $132K | Buy |
5,238
+423
| +9% | +$10K | ﹤0.01% | 4827 |
|
|
2014
Q4 | $108K | Sell |
4,815
-3,209
| -40% | -$65.1K | ﹤0.01% | 5182 |
|
|
2014
Q3 | $163K | Buy |
8,024
+1,433
| +22% | +$28.5K | ﹤0.01% | 4377 |
|
|
2014
Q2 | $127K | Sell |
6,591
-4,565
| -41% | -$85.1K | ﹤0.01% | 4496 |
|
|
2014
Q1 | $210K | Sell |
11,156
-20,587
| -65% | -$397K | ﹤0.01% | 4279 |
|
|
2013
Q4 | $619K | Buy |
31,743
+5,676
| +22% | +$104K | ﹤0.01% | 3620 |
|
|
2013
Q3 | $429K | Sell |
26,067
-5,845
| -18% | -$93.8K | ﹤0.01% | 3555 |
|
|
2013
Q2 | $477K | Buy |
+31,912
| New | +$468K | ﹤0.01% | 3519 |
|
Other funds holding IART
RCMNY
PCMI
Citigroup's IART Position: Q2 2026 in Review
Citigroup increased its Integra LifeSciences (IART) stake by 324% in Q2 2026, buying an estimated $471K and bringing the position to 44,078 shares worth $792K. The position accounts for ﹤0.01% of the portfolio, ranked #3622.
Citigroup first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.4M in Q1 2022. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Citigroup held 44,078 shares of Integra LifeSciences worth $792K as of Q2 2026.
- Citigroup bought 33,672 Integra LifeSciences shares in Q2 2026, an estimated $471K.
- Integra LifeSciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3622 holding.
- Citigroup first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Citigroup's Integra LifeSciences position peaked at $31.4M in Q1 2022.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.